Chemotherapy for uterine cancer

Last medical review:

Chemotherapy uses drugs to destroy cancer cells. These drugs target rapidly dividing cells throughout the whole body. This means that chemotherapy kills cancer cells but it can also damage healthy cells.

With most types of chemotherapy, the drugs travel through the blood to reach and destroy cancer cells all over the body, including cells that may have broken away from the primary tumour. This is described as systemic therapy.

Chemotherapy is sometimes used to treat both endometrial carcinoma and uterine sarcoma. If you have chemotherapy, your healthcare team will use what they know about the cancer and about your health to plan the drugs, doses and schedules.

Chemotherapy may be the only treatment you have or it may be used along with other cancer treatments. You may have chemotherapy or chemoradiation to:

  • destroy cancer cells left behind after surgery and reduce the risk that the cancer will come back (recur) (called adjuvant chemotherapy)

  • relieve pain or control the symptoms of advanced or metastatic uterine cancer (called palliative chemotherapy)

  • try to shrink a tumour before surgery to try to make it operable (called neoadjuvant chemotherapy)

Most people with uterine cancer who have chemotherapy will be given 2 or more chemotherapy drugs during the same time period. This is called a chemotherapy drug combination.

Chemotherapy and radiation therapy may be given during the same time period for uterine sarcoma. This is called chemoradiation. Some chemotherapy drugs can help make radiation work better by making cancer cells more sensitive to radiation. Combining chemotherapy and radiation therapy can be more effective than either treatment on its own.

Chemotherapy drugs used for uterine cancer

The types and combinations of chemotherapy drugs used vary depending on the type of tumour being treated.

Endometrial carcinoma

The most common chemotherapy drug combinations used to treat endometrial carcinoma are:

  • cisplatin (or carboplatin) and paclitaxel
  • carboplatin and docetaxel
  • carboplatin and nab-paclitaxel
  • cisplatin (or carboplatin) and doxorubicin
  • paclitaxel, ifosfamide and mesna
  • carboplatin and paclitaxel with the targeted therapy drug trastuzumab (Herceptin and biosimilars)
  • carboplatin and paclitaxel with the immunotherapy drug dostarlimab-gxly (Jemperli)
  • carboplatin and paclitaxel with the immunotherapy drug durvalumab (Imfinzi)
  • cyclophosphamide, doxorubicin and vincristine

The most common chemotherapy drugs used alone to treat endometrial carcinoma are:

  • paclitaxel
  • cisplatin
  • doxorubicin
  • carboplatin

Uterine sarcoma

The most common chemotherapy drug combinations used to treat uterine sarcoma are:

  • docetaxel and gemcitabine
  • doxorubicin and cisplatin
  • doxorubicin, ifosfamide and mesna
  • ifosfamide and mesna
  • doxorubicin and dacarbazine
  • doxorubicin and trabectedin

The most common chemotherapy drugs used alone to treat uterine sarcoma are:

  • doxorubicin
  • gemcitabine
  • carboplatin
  • ifosfamide
  • dacarbazine
  • trabectedin

Side effects of chemotherapy

Side effects of chemotherapy will depend mainly on the type of drug, the dose, how it's given and your overall health. Tell your healthcare team if you have these side effects or others you think might be from chemotherapy. The sooner you tell them of any problems, the sooner they can suggest ways to help you deal with them.

Common side effects of chemotherapy drugs used for uterine cancer are:

Doxorubicin may also cause heart problems. Cisplatin may also cause peripheral nerve damage.

Find out more about chemotherapy

Find out more about chemotherapy and side effects of chemotherapy. To make the decisions that are right for you, ask your healthcare team questions about chemotherapy.

Details on specific drugs change quite regularly. Find out more about sources of drug information and where to get details on specific drugs.

Expert review and references

  • Tien Le, MD, FRCSC, DABOG
  • American Cancer Society. Chemotherapy for Endometrial Cancer. 2019. https://www.cancer.org/.
  • American Cancer Society. Chemotherapy for Uterine Sarcomas. 2022. https://www.cancer.org/.
  • American Cancer Society. Treatment Choices for Endometrial Cancer, by Stage. 2022. https://www.cancer.org/.
  • American Cancer Society. Treatment for Uterine Sarcoma, by Type and Stage. 2022. https://www.cancer.org/.
  • Cancer Research UK. Chemotherapy for Womb Cancer. 2024. https://www.cancerresearchuk.org/.
  • Endometrium. Provincial Health Services Authority. Cancer Management Manual. BC Cancer; 2023. http://www.bccancer.bc.ca/.
  • Guideline Resource Unit (GURU). Uterine Sarcoma. Edmonton, AB: Alberta Health Services; 2023: Clinical Practice Guideline GYNE-007 Version: 3. ​https://www.albertahealthservices.ca/info/cancerguidelines.aspx​.
  • Hamilton CA, Pothuri B, Arend RC, et al. Endometrial cancer: A society of gynecologic oncology evidence-based review and recommendations. Gynecologic Oncology. 2021: 160:817–826.
  • Hamilton CA, Pothuri B, Arend RC, et al. Endometrial cancer: A society of gynecologic oncology evidence-based review and recommendations, part II. Gynecologic Oncology. 2021: 160:827–834.
  • Princess Margaret Cancer Centre clinical practice guidelines for gynecologic cancer – endometrial. Princess Margaret Cancer Centre Gynecologic Site Group. Princess Margaret Cancer Program Clinical Practice Guidelines. University Health Network; 2015: Laframboise S. https://www.uhn.ca/PrincessMargaret/Health_Professionals/Programs_Departments/Pages/clinical_practice_guidelines.aspx.
  • National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®): Uterine Neoplasms (Version 3.2024). 2024.
  • PDQ Adult Treatment Editorial Board. Endometrial Cancer Treatment (PDQ®)–Health Professional Version. National Cancer Institute; 2024. https://www.cancer.gov/.
  • PDQ Adult Treatment Editorial Board. Uterine Sarcoma Treatment (PDQ®)–Health Professional Version. National Cancer Institute; 2022. https://www.cancer.gov/.
  • Saskatchewan Cancer Agency. SCA Drug Formulary. https://saskcancer.ca/. November 08, 2024.

Your trusted source for accurate cancer information

With support from readers like you, we can continue to provide the highest quality cancer information for over 100 types of cancer.

We’re here to ensure easy access to accurate cancer information for you and the millions of people who visit this website every year. But we can’t do it alone.

Every donation helps fund reliable cancer information, compassionate support services and the most promising research. Please give today because every contribution counts. Thank you.

Medical disclaimer

The information that the Canadian Cancer Society provides does not replace your relationship with your doctor. The information is for your general use, so be sure to talk to a qualified healthcare professional before making medical decisions or if you have questions about your health.

We do our best to make sure that the information we provide is accurate and reliable but cannot guarantee that it is error-free or complete.

The Canadian Cancer Society is not responsible for the quality of the information or services provided by other organizations and mentioned on cancer.ca, nor do we endorse any service, product, treatment or therapy.


1-888-939-3333 | cancer.ca | © 2025 Canadian Cancer Society